You are here
Coronavirus (COVID-19): Information on medicines and medical devices
The TGA is publishing the latest information about medicines and medical devices as it relates to COVID-19 on this page.
Please read the information below before contacting the TGA to see if your question is already answered.
Filters
Topics and product types
I want to
- Find out about medicine shortages and restrictions (5) Apply Find out about medicine shortages and restrictions filter
- Report a perceived breach or questionable practices (1) Apply Report a perceived breach or questionable practices filter
- Supply a COVID-19 test kit (3) Apply Supply a COVID-19 test kit filter
- Supply a face mask, gloves or gown (1) Apply Supply a face mask, gloves or gown filter
3 March 2021
The TGA is undertaking a post-market review of face masks included in the ARTG. This page lists all face masks that have been cancelled from the ARTG during the review.
1 March 2021
This page provides information for consumers and health professionals on how to report suspected side effects (adverse events) associated with a COVID-19 vaccine.
26 February 2021
The TGA has received applications and is assessing preliminary data for three COVID-19 vaccines using the provisional pathway and rolling review procedures.
25 February 2021
The TGA has issued four infringement notices to Sydney-based company for the alleged unlawful importation of infrared thermometers, rigid strapping tapes and iodine prep pads.
22 February 2021
Find information on complying with the rules around advertising and importing COVID-19 vaccines
16 February 2021
The TGA has granted provisional approval to AstraZeneca Pty Ltd for its COVID-19 vaccine
16 February 2021
The TGA has granted provisional approval to AstraZeneca Pty Ltd for its COVID-19 vaccine
11 February 2021
This page compiles all of our resources related to face masks and COVID-19.
11 February 2021
A list of disinfectant products included in the ARTG with specific claims against SARS-Cov-2 (COVID 19) or COVID-19 on the product label.
9 February 2021
The plan outlines five key strategies to strengthen Australia's vaccine vigilance system.
Pages
Further information
Contact TGA Info
Tel: 1800 020 653
Email: info@tga.gov.au
Note: we are currently experiencing a high volume of calls and emails. Please bear with us as we try to respond to queries as quickly as possible.
Department of Health
Coronavirus (COVID-19) health alert — for information and advice not specific to therapeutic goods.
Follow us
